TET2 c.368G>T ;(p.R123L)

Variant ID: 4-106155467-G-T

NM_001127208.2(TET2):c.368G>T;(p.R123L)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Comprehensive next-generation profiling of clonal hematopoiesis in cancer patients using paired tumor-blood sequencing for guiding personalized therapies.

Clinical And Translational Medicine
Li, Ziyang Z; Huang, Wensou W; Yin, Jiani C JC; Na, Chenglong C; Wu, Xue X; Shao, Yang Y; Ding, Huaxin H; Li, Jinming J
Publication Date: 2020-11

Variant appearance in text: rs773565437
PubMed Link: 33252848
Variant Present in the following documents:
  • CTM2-10-e222-s003.xlsx, sheet 1
View BVdb publication page



Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics.

Frontiers In Oncology
Golub, Danielle D; Iyengar, Nishanth N; Dogra, Siddhant S; Wong, Taylor T; Bready, Devin D; Tang, Karen K; Modrek, Aram S AS; Placantonakis, Dimitris G DG
Publication Date: 2019

Variant appearance in text: TET2: R123L
PubMed Link: 31165048
Variant Present in the following documents:
  • Main text
View BVdb publication page



appreci8: a pipeline for precise variant calling integrating 8 tools.

Bioinformatics (Oxford, England)
Sandmann, Sarah S; Karimi, Mohsen M; de Graaf, Aniek O AO; Rohde, Christian C; Göllner, Stefanie S; Varghese, Julian J; Ernsting, Jan J; Walldin, Gunilla G; van der Reijden, Bert A BA; Müller-Tidow, Carsten C; Malcovati, Luca L; Hellström-Lindberg, Eva E; Jansen, Joop H JH; Dugas, Martin M
Publication Date: 2018-12-15

Variant appearance in text: TET2: 368G>T; Arg123Leu
PubMed Link: 29945233
Variant Present in the following documents:
  • bty518_supplementary_data_s3.xlsx, sheet 9
View BVdb publication page